This inventor holds 1 USPTO granted patent. Top assignees: Temple Therapeutics, Inc., Texas A&M University System. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Fei Liu - Innovator in Stem Cell Research
Introduction
Fei Liu is a notable inventor based in Belton, Texas, recognized for her contributions to the field of stem cell research. With a focus on developing innovative methods for producing mesenchymal stem cells, her work has significant implications for therapeutic applications.
Latest Patents
Fei Liu holds a patent for a method of producing mesenchymal stem cells derived from induced pluripotent stem cells. This patent describes a process in which induced pluripotent stem cells are cultured in the presence of a TGF-β inhibitor and in an atmosphere containing approximately 7 to 8 vol. % CO2 for a duration of 20 to 35 days. The resulting mesenchymal stem cells are more stable and have a reduced likelihood of forming tumors, cancers, or teratomas. Additionally, the induced pluripotent stem cells can be genetically engineered to express therapeutic agents, enhancing their potential for medical applications.
Career Highlights
Throughout her career, Fei Liu has worked with esteemed organizations, including the Texas A&M University System and Temple Therapeutics, Inc. Her research has contributed to advancements in regenerative medicine and cellular therapies.
Collaborations
Fei Liu has collaborated with prominent researchers in her field, including Darwin J. Prockop and Qingguo Zhao. These partnerships have fostered innovative research and development in stem cell technology.
Conclusion
Fei Liu's work in stem cell research exemplifies the potential of innovative methods to advance medical science. Her contributions continue to pave the way for future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile